WallStreetZenWallStreetZen

NASDAQ: CERO
Cero Therapeutics Holdings Inc Stock Ownership - Who owns Cero Therapeutics Holdings?

Insider buying vs selling

Have Cero Therapeutics Holdings Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when CERO insiders and whales buy or sell their stock.

CERO Shareholders

What type of owners hold Cero Therapeutics Holdings Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Christopher B. Ehrlich12.43%1,482,425$6.20MInsider
Phoenix Biotech Sponsor LLC8.38%1,000,000$4.18MInsider
Brian G. Atwood3.13%373,735$1.56MInsider
Daniel Corey2.34%278,687$1.16MInsider
Meteora Capital LLC2.03%242,687$1.01MInstitution
Cantor Fitzgerald L P1.30%155,000$647.90kInstitution
Mint Tower Capital Management Bv1.18%141,089$589.75kInstitution
Yakira Capital Management Inc0.91%108,103$451.87kInstitution
Clear Street LLC0.46%54,942$229.66kInstitution
Robyn Rapaport0.42%50,000$209.00kInsider

1 of 3

CERO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CERO7.00%27.38%
ICCC13.45%24.31%Net Buying
YS10.08%0.00%
ESLA0.35%80.34%Net Selling
OKYO0.15%99.85%Net Buying

Cero Therapeutics Holdings Stock Ownership FAQ

Who owns Cero Therapeutics Holdings?

Cero Therapeutics Holdings (NASDAQ: CERO) is owned by 7.00% institutional shareholders, 27.38% Cero Therapeutics Holdings insiders, and 65.62% retail investors. Christopher B. Ehrlich is the largest individual Cero Therapeutics Holdings shareholder, owning 1.48M shares representing 12.43% of the company. Christopher B. Ehrlich's Cero Therapeutics Holdings shares are currently valued at $4.82M.

If you're new to stock investing, here's how to buy Cero Therapeutics Holdings stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.